Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Lazard A | LAZ | Nov 15, 2024 | 55.00 | -1.36 |
Lazard Global Total Return and Income Fund | LGI | Nov 15, 2024 | 16.35 | -1.39 |
Lazydays | GORV | Nov 15, 2024 | 1.13 | +9.71 |
LCI Industries | LCII | Nov 15, 2024 | 114.69 | +0.42 |
LCNB | LCNB | Nov 15, 2024 | 16.84 | +0.18 |
Lead Real Estate ADR | LRE | Nov 15, 2024 | 2.11 | +4.21 |
Leafly | LFLY | Nov 15, 2024 | 1.54 | -1.28 |
Leap Therapeutics | LPTX | Nov 15, 2024 | 2.74 | -5.19 |
Lear | LEA | Nov 15, 2024 | 95.61 | -0.47 |
LeddarTech | LDTC | Nov 15, 2024 | 0.32 | -1.76 |
Lee Enterprises | LEE | Nov 15, 2024 | 16.30 | -0.67 |
Legacy Housing | LEGH | Nov 15, 2024 | 25.89 | -0.04 |
LegalZoom.com | LZ | Nov 15, 2024 | 7.73 | -3.25 |
Legato Merger III | LEGT | Nov 15, 2024 | 10.29 | +0.19 |
Legend Biotech ADR | LEGN | Nov 15, 2024 | 38.19 | -4.26 |
Legg Mason Low Volatility High Dividend ETF | LVHD | Nov 15, 2024 | 39.86 | -0.25 |
Leggett & Platt | LEG | Nov 15, 2024 | 11.82 | +0.17 |
Leidos | LDOS | Nov 15, 2024 | 160.65 | -4.35 |
LeMaitre Vascular | LMAT | Nov 15, 2024 | 102.02 | +0.49 |
Lemonade | LMND | Nov 15, 2024 | 33.30 | +5.01 |
LendingClub | LC | Nov 15, 2024 | 14.92 | -1.32 |
LendingTree | TREE | Nov 15, 2024 | 44.34 | -8.48 |
Lendway | LDWY | Nov 15, 2024 | 3.69 | +7.55 |
Lennar A | LEN | Nov 15, 2024 | 168.85 | -0.56 |
Lennar B | LEN-B | Nov 15, 2024 | 159.53 | -0.51 |
Lennox International | LII | Nov 15, 2024 | 610.15 | -1.25 |
LENSAR | LNSR | Nov 15, 2024 | 7.08 | -1.67 |
LENZ Therapeutics | LENZ | Nov 15, 2024 | 33.20 | -2.15 |
Leonardo DRS | DRS | Nov 15, 2024 | 33.72 | -1.78 |
Lesaka Technologies | LSAK | Nov 15, 2024 | 5.02 | -1.95 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.